Global Next-Generation Complement Therapeutics Market to Surge Significantly at a CAGR of ~15% by 2030 | DelveInsight
August 08, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Global Next-Generation Complement Therapeutics Market to Surge Significantly at a CAGR of ~15% by 2030 | DelveInsight The next-generation...
Global Stem Cell Market to Cross ~USD 29 Billion Mark by 2030 | DelveInsight
August 08, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Global Stem Cell Market to Cross ~USD 29 Billion Mark by 2030 | DelveInsight The stem cell market is experiencing positive growth due to several...
Consumers purchasing short-term health insurance plans will soon see new duration limits
August 08, 2024 11:42 ET
|
healthinsurance.org
Minneapolis, MN, Aug. 08, 2024 (GLOBE NEWSWIRE) -- On Sept. 1, a new federal rule will apply a four-month limit on the duration of short-term health insurance plans — including renewals — unless a...
Association of Corporate Counsel Launches New Well-being Toolkit for In-house Lawyers
August 08, 2024 11:00 ET
|
Association of Corporate Counsel
Washington, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The Association of Corporate Counsel (ACC), the premier global legal association for in-house counsel, today launched the ACC Well-being Toolkit for...
Canada's First Precision Health and Longevity Summit Aims to Advance Global Healthspan Research
August 08, 2024 09:47 ET
|
BioAro
Join Canada’s first Precision Health & Longevity Summit on Nov 16, 2024, at The Westin Calgary. Explore innovations in precision medicine & healthspan.
Non-Thermal Pasteurization Market Size, Share and Industry Forecast
August 08, 2024 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The non-thermal pasteurization market is projected to reach USD 5.7 billion by 2028 from USD 2.3 billion by 2023, at a CAGR of 20.0% during the forecast...
Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing
August 08, 2024 08:45 ET
|
Oragenics
SARASOTA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological...
Crinetics Launches ACRO/TRUTH Educational Initiative to Raise Awareness of Acromegaly Treatment Challenges
August 08, 2024 08:30 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the launch of the ACRO/TRUTH healthcare provider (HCP) educational website and initiative,...
IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.
August 08, 2024 08:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...
Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September
August 08, 2024 08:00 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, is...